FLR Form 144: David Constable proposes sale of 71,200 shares valued at $4.01M

Rhea-AI Filing Summary

David Constable filed a Form 144 disclosing a proposed sale of 71,200 shares of Fluor Corporation common stock through Merrill Lynch, showing an aggregate market value of $4,014,800.00 and an approximate sale date of 08/11/2025 on the NYSE. The filing records that the securities were originally acquired on 03/06/2024 as restricted stock from Fluor Corporation under an equity award, totaling 277,649 shares acquired on that date.

The notice also itemizes recent insider sales: 38,600 shares on 07/03/2025 (gross proceeds $2,009,702.05), 40,000 on 06/16/2025 (gross proceeds $2,003,972.04), and 40,800 on 06/11/2025 (gross proceeds $1,997,302.47). The filing states total shares outstanding of 161,664,371 and includes the filer’s representation that they are not aware of any undisclosed material adverse information about the issuer.

Positive

• Full compliance disclosure with Rule 144: proposed sale, acquisition details, broker, and recent sales with gross proceeds are all reported
• Acquisition basis disclosed (restricted stock received under an equity award on 03/06/2024), improving transparency about insider holdings

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider Form 144 showing proposed sale and prior transactions; amounts disclosed but not material in isolation.

The filing documents a proposed disposition of 71,200 Fluor shares and lists three recent sales totaling 119,400 shares with gross proceeds disclosed for each trade. The securities were acquired as restricted stock under an equity award on 03/06/2024. For investors, this is primarily a transparency and compliance update under Rule 144 rather than a new operational development. Transaction sizes and explicit gross proceeds are provided, enabling straightforward verification against market activity.

Corporate Governance Expert

TL;DR: Filing reflects standard insider reporting and includes the required attestation about material nonpublic information.

The Form 144 provides the necessary disclosures: identity of the seller shown in prior-sales entries, acquisition details (restricted stock, equity award), broker name, and amounts. The inclusion of the filer’s representation that they do not possess undisclosed material adverse information is the prescribed compliance statement. This submission meets disclosure expectations but does not in itself change governance or operational outlook for the company.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	MERRILL LYNCH 13355 NOEL ROAD SUITE 700 DALLAS TX 75240	71200	4014800.00	161664371	08/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	03/06/2024	RESTRICTED STOCK	FLUOR CORPORATION			277649	03/06/2024	EQUITY AWARD

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DAVID CONSTABLE 6700 LAS COLINAS BLVD IRVING TX 75039	COMMON	07/03/2025	38600	2009702.05
DAVID CONSTABLE 6700 LAS COLINAS BLVD IRVING TX 75039	COMMON	06/16/2025	40000	2003972.04
DAVID CONSTABLE 6700 LAS COLINAS BLVD IRVING TX 75039	COMMON	06/11/2025	40800	1997302.47

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Fluor (FLR) Form 144 disclose about the proposed sale?

The Form 144 shows a proposed sale of 71,200 Fluor common shares with an aggregate market value of $4,014,800.00, to be executed approximately on 08/11/2025 on the NYSE.

Who is identified in the filing as selling FLR shares?

The recent-sales entries identify David Constable (address listed) as the seller in transactions included in the filing.

What recent insider sales are disclosed for FLR in the past three months?

The filing lists three sales: 38,600 shares on 07/03/2025 for $2,009,702.05; 40,000 shares on 06/16/2025 for $2,003,972.04; and 40,800 shares on 06/11/2025 for $1,997,302.47.

How were the shares being sold originally acquired?

The securities proposed for sale include shares acquired on 03/06/2024 as restricted stock from Fluor Corporation under an equity award, totaling 277,649 shares acquired on that date.

Does the filing state whether the filer knows any undisclosed material information about FLR?

Yes. By signing, the person for whose account the sale is proposed represents they do not know any material adverse information